{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:44:18Z","timestamp":1792709058333,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/cdd.2017.6","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T15:32:51Z","timestamp":1486740771000},"page":"705-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["EVI2B is a C\/EBP\u03b1 target gene required for granulocytic differentiation and functionality of hematopoietic progenitors"],"prefix":"10.1038","volume":"24","author":[{"given":"Polina","family":"Zjablovskaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Kardosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Danek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Angelisova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Touati","family":"Benoukraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A","family":"Wurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Balastik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Delwel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Brdicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G","family":"Tenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Behre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9deric","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Malissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaclav","family":"Horejsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Alberich-Jorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"BFcdd20176_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/35049577","volume":"1","author":"SH Orkin","year":"2000","unstructured":"Orkin SH . Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet 2000; 1: 57\u201364.","journal-title":"Nat Rev Genet"},{"key":"BFcdd20176_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B Lowenberg","year":"1999","unstructured":"Lowenberg B, Downing JR, Burnett A . Acute myeloid leukemia. N Engl J Med 1999; 341: 1051\u20131062.","journal-title":"N Engl J Med"},{"key":"BFcdd20176_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/bj20020508","volume":"365","author":"DP Ramji","year":"2002","unstructured":"Ramji DP, Foka P . CCAAT\/enhancer-binding proteins: structure, function and regulation. Biochem J 2002; 365: 561\u2013575.","journal-title":"Biochem J"},{"key":"BFcdd20176_CR4","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1128\/MCB.18.7.4301","volume":"18","author":"HS Radomska","year":"1998","unstructured":"Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG . CCAAT\/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 1998; 18: 4301\u20134314.","journal-title":"Mol Cell Biol"},{"key":"BFcdd20176_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","volume":"21","author":"P Zhang","year":"2004","unstructured":"Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, Owens BM et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP alpha. Immunity 2004; 21: 853\u2013863.","journal-title":"Immunity"},{"key":"BFcdd20176_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ncb2698","volume":"15","author":"M Ye","year":"2013","unstructured":"Ye M, Zhang H, Amabile G, Yang H, Staber PB, Zhang P et al. C\/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol 2013; 15: 385\u2013394.","journal-title":"Nat Cell Biol"},{"key":"BFcdd20176_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nrc1363","volume":"4","author":"C Nerlov","year":"2004","unstructured":"Nerlov C . C\/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer 2004; 4: 394\u2013400.","journal-title":"Nat Rev Cancer"},{"key":"BFcdd20176_CR8","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2008-09-179895","volume":"113","author":"BJ Wouters","year":"2009","unstructured":"Wouters BJ, Lowenberg B, Erpelinck-Verschueren CA, van Putten WL, Valk PJ, Delwel R . Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood 2009; 113: 3088\u20133091.","journal-title":"Blood"},{"key":"BFcdd20176_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.leu.2403614","volume":"19","author":"H Leroy","year":"2005","unstructured":"Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C . CEBPA point mutations in hematological malignancies. Leukemia 2005; 19: 329\u2013334.","journal-title":"Leukemia"},{"key":"BFcdd20176_CR10","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1182\/blood-2002-03-0990","volume":"100","author":"C Preudhomme","year":"2002","unstructured":"Preudhomme C, Sagot C, Boissel N, Cayuela JM, Tigaud I, de Botton S et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood 2002; 100: 2717\u20132723.","journal-title":"Blood"},{"key":"BFcdd20176_CR11","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1182\/blood-2010-09-307280","volume":"117","author":"E Taskesen","year":"2011","unstructured":"Taskesen E, Bullinger L, Corbacioglu A, Sanders MA, Erpelinck CA, Wouters BJ et al. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood 2011; 117: 2469\u20132475.","journal-title":"Blood"},{"key":"BFcdd20176_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/85820","volume":"27","author":"T Pabst","year":"2001","unstructured":"Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S et al. Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBPalpha), in acute myeloid leukemia. Nat Genet 2001; 27: 263\u2013270.","journal-title":"Nat Genet"},{"key":"BFcdd20176_CR13","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1182\/blood-2007-02-073486","volume":"110","author":"BJ Wouters","year":"2007","unstructured":"Wouters BJ, Jorda MA, Keeshan K, Louwers I, Erpelinck-Verschueren CA, Tielemans D et al. Distinct gene expression profiles of acute myeloid\/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood 2007; 110: 3706\u20133714.","journal-title":"Blood"},{"key":"BFcdd20176_CR14","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1046\/j.1365-2141.2002.03952.x","volume":"119","author":"CS Chim","year":"2002","unstructured":"Chim CS, Wong AS, Kwong YL . Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia. Br J Haematol 2002; 119: 988\u2013990.","journal-title":"Br J Haematol"},{"key":"BFcdd20176_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ng791","volume":"30","author":"D Perrotti","year":"2002","unstructured":"Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K et al. BCR-ABL suppresses C\/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet 2002; 30: 48\u201358.","journal-title":"Nat Genet"},{"key":"BFcdd20176_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1128\/MCB.24.2.675-686.2004","volume":"24","author":"SE Ross","year":"2004","unstructured":"Ross SE, Radomska HS, Wu B, Zhang P, Winnay JN, Bajnok L et al. Phosphorylation of C\/EBPalpha inhibits granulopoiesis. Mol Cell Biol 2004; 24: 675\u2013686.","journal-title":"Mol Cell Biol"},{"key":"BFcdd20176_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1084\/jem.20052242","volume":"203","author":"HS Radomska","year":"2006","unstructured":"Radomska HS, Basseres DS, Zheng R, Zhang P, Dayaram T, Yamamoto Y et al. Block of C\/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med 2006; 203: 371\u2013381.","journal-title":"J Exp Med"},{"key":"BFcdd20176_CR18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3324\/haematol.2013.093278","volume":"99","author":"A Liss","year":"2014","unstructured":"Liss A, Ooi CH, Zjablovskaja P, Benoukraf T, Radomska HS, Ju C et al. The gene signature in CCAAT-enhancer-binding protein alpha dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors. Haematologica 2014; 99: 697\u2013705.","journal-title":"Haematologica"},{"key":"BFcdd20176_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/0888-7543(91)90410-G","volume":"9","author":"RM Cawthon","year":"1991","unstructured":"Cawthon RM, Andersen LB, Buchberg AM, Xu GF, O'Connell P, Viskochil D et al. cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene. Genomics 1991; 9: 446\u2013460.","journal-title":"Genomics"},{"key":"BFcdd20176_CR20","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1128\/MCB.10.9.4658","volume":"10","author":"AM Buchberg","year":"1990","unstructured":"Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG . Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol 1990; 10: 4658\u20134666.","journal-title":"Mol Cell Biol"},{"key":"BFcdd20176_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.imlet.2010.09.019","volume":"134","author":"J Matesanz-Isabel","year":"2011","unstructured":"Matesanz-Isabel J, Sintes J, Llinas L, de Salort J, Lazaro A, Engel P . New B-cell CD molecules. Immunol Lett 2011; 134: 104\u2013112.","journal-title":"Immunol Lett"},{"key":"BFcdd20176_CR22","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1182\/blood-2003-02-0479","volume":"102","author":"F D'Alo","year":"2003","unstructured":"D'Alo F, Johansen LM, Nelson EA, Radomska HS, Evans EK, Zhang P et al. The amino terminal and E2F interaction domains are critical for C\/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells. Blood 2003; 102: 3163\u20133171.","journal-title":"Blood"},{"key":"BFcdd20176_CR23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/ni1354","volume":"7","author":"H Hirai","year":"2006","unstructured":"Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, Imanishi J et al. C\/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol 2006; 7: 732\u2013739.","journal-title":"Nat Immunol"},{"key":"BFcdd20176_CR24","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1172\/JCI65102","volume":"122","author":"M Alberich-Jorda","year":"2012","unstructured":"Alberich-Jorda M, Wouters B, Balastik M, Shapiro-Koss C, Zhang H, Di Ruscio A et al. C\/EBPgamma deregulation results in differentiation arrest in acute myeloid leukemia. J Clin investig 2012; 122: 4490\u20134504.","journal-title":"J Clin investig"},{"key":"BFcdd20176_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3324\/haematol.13299","volume":"94","author":"RG Verhaak","year":"2009","unstructured":"Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, Lugthart S et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 2009; 94: 131\u2013134.","journal-title":"Haematologica"},{"key":"BFcdd20176_CR26","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.1128\/MCB.13.12.7774","volume":"13","author":"F Dong","year":"1993","unstructured":"Dong F, van Buitenen C, Pouwels K, Hoefsloot LH, Lowenberg B, Touw IP . Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 1993; 13: 7774\u20137781.","journal-title":"Mol Cell Biol"},{"key":"BFcdd20176_CR27","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1182\/blood-2002-07-2034","volume":"101","author":"MA Jorda","year":"2003","unstructured":"Jorda MA, Lowenberg B, Delwel R . The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. Blood 2003; 101: 1336\u20131343.","journal-title":"Blood"},{"key":"BFcdd20176_CR28","doi-asserted-by":"publisher","first-page":"10968","DOI":"10.1038\/ncomms10968","volume":"7","author":"D Bararia","year":"2016","unstructured":"Bararia D, Kwok HS, Welner RS, Numata A, Sarosi MB, Yang H et al. Acetylation of C\/EBPalpha inhibits its granulopoietic function. Nat Commun 2016; 7: 10968.","journal-title":"Nat Commun"},{"key":"BFcdd20176_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/86515","volume":"7","author":"T Pabst","year":"2001","unstructured":"Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G et al. AML1-ETO downregulates the granulocytic differentiation factor C\/EBPalpha in t(8;21) myeloid leukemia. Nat Med 2001; 7: 444\u2013451.","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1038\/s41418-018-0146-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000}}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd20176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd20176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd20176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:13:29Z","timestamp":1684415609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd20176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFcdd20176"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2017.6","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41418-018-0146-z","asserted-by":"object"}]},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]},"assertion":[{"value":"28 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}